AbbVie (ABBV)

AbbVie (ABBV) Financial Statements


AbbVie Financial Overview

AbbVie's market cap is currently ―. The company's EPS TTM is $2.72; its P/E ratio is 59.69; and it has a dividend yield of 3.69%. AbbVie is scheduled to report earnings on April 26, 2024, and the estimated EPS forecast is $2.28. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 14.30B$ 13.93B$ 13.87B$ 12.22B$ 15.12B
Gross Profit$ 8.60B$ 7.44B$ 9.63B$ 8.24B$ 10.95B
EBIT$ 1.78B$ 2.51B$ 3.16B$ -78.00M$ 3.44B
EBITDA$ 3.76B$ 4.80B$ 5.45B$ 2.00B$ 5.64B
Net Income Common Stockholders$ 822.00M$ 1.78B$ 2.02B$ 239.00M$ 2.47B
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 12.82B$ 13.29B$ 8.77B$ 6.72B$ 9.23B
Total Assets$ 134.71B$ 136.22B$ 135.37B$ 134.54B$ 138.81B
Total Debt$ 59.38B$ 60.75B$ 61.02B$ 62.09B$ 63.27B
Net Debt$ 46.57B$ 47.46B$ 52.25B$ 55.37B$ 54.04B
Total Liabilities$ 124.31B$ 124.09B$ 122.47B$ 121.24B$ 138.81B
Stockholders Equity$ 10.36B$ 12.09B$ 12.87B$ 13.27B$ 17.25B
Cash Flow-
Free Cash Flow$ 4.55B$ 11.23B$ 4.34B$ 1.95B$ 5.59B
Operating Cash Flow$ 4.75B$ 11.45B$ 6.32B$ 2.12B$ 5.81B
Investing Cash Flow$ -800.00M$ -3.79B$ -341.00M$ 1.37B$ 1.67B
Financing Cash Flow$ -4.45B$ -3.09B$ -3.92B$ -6.04B$ -10.09B
Currency in USD

AbbVie Earnings and Revenue History

AbbVie Debt to Assets

AbbVie Cash Flow

AbbVie Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis